Amarilis Perez‐De Jesus

Research Areas

Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Spondyloarthritis Studies and Treatments, Autoimmune and Inflammatory Disorders Research, Autoimmune Bullous Skin Diseases

Most-Cited Works

• → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited